Thus, the presence of clonal CD8+ T cells, given their cytotoxic capabilities, underscore the possible role of CD8+ T cells in dopaminergic neurodegeneration and highlight their potential as therapeutic targets, however, their role in PD etiology and disease progression has yet to be determined. This evidence concerns the gene CD8A and Parkinson disease.